IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	77.64	73.24	65.56	53.3	41.81	31.72
Revenue Growth (YoY)	11.73%	11.71%	23.00%	27.47%	31.84%	-17.65%
Cost of Revenue	17.88	16.89	15.4	12.02	9.76	8.14
Gross Profit	59.75	56.35	50.16	41.28	32.05	23.57
Selling, General & Admin	33.27	31.59	27.3	23.41	20.36	19.76
Research & Development	2.67	2.8	2.82	2.24	1.87	1.87
Operating Expenses	35.94	34.39	30.12	25.65	22.23	21.63
Operating Income	23.81	21.96	20.04	15.63	9.82	1.94
Interest & Investment Income	2.19	2.19	1.86	0.58	0.03	0.13
Currency Exchange Gain (Loss)	-0.04	-0.04	-0.15	-0.04	-0.03	-0.01
Other Non Operating Income (Expenses)	0.08	0.16	-	-	-	-
EBT Excluding Unusual Items	26.04	24.28	21.75	16.17	9.82	2.07
Gain (Loss) on Sale of Investments	-	-	-	0.01	0.02	0.02
Gain (Loss) on Sale of Assets	-0	-0	-0.01	-	-	-
Other Unusual Items	-	-	-	-	-	-2.7
Pretax Income	26.04	24.28	21.74	16.18	9.84	-0.62
Income Tax Expense	5.38	5.04	4.55	3.35	0.51	-1.99
Net Income	20.66	19.23	17.19	12.83	9.33	1.37
Net Income to Common	20.66	19.23	17.19	12.83	9.33	1.37
Net Income Growth	10.80%	11.87%	34.02%	37.56%	581.19%	-85.78%
Shares Outstanding (Basic)	13	13	13	13	12	12
Shares Outstanding (Diluted)	13	13	13	13	13	12
Shares Change (YoY)	0.59%	0.48%	0.69%	0.36%	1.21%	1.33%
EPS (Basic)	1.63	1.52	1.36	1.02	0.76	0.11
EPS (Diluted)	1.61	1.50	1.35	1.02	0.74	0.11
EPS Growth	10.28%	11.11%	32.35%	37.84%	572.73%	-85.90%
Free Cash Flow	14.21	17.62	6.02	9.22	10.78	5.37
Free Cash Flow Per Share	1.11	1.38	0.47	0.73	0.86	0.43
Dividend Per Share	0.660	0.470	0.150	-	-	-
Dividend Growth	120.00%	213.33%	-	-	-	-
Gross Margin	76.96%	76.94%	76.50%	77.45%	76.65%	74.33%
Operating Margin	30.67%	29.99%	30.56%	29.32%	23.48%	6.13%
Profit Margin	26.61%	26.26%	26.22%	24.07%	22.30%	4.32%
Free Cash Flow Margin	18.30%	24.06%	9.19%	17.30%	25.77%	16.95%
EBITDA	24.6	22.78	20.8	16.3	11.22	3.28
EBITDA Margin	31.69%	31.11%	31.73%	30.58%	26.84%	10.35%
D&A For EBITDA	0.79	0.82	0.77	0.67	1.41	1.34
EBIT	23.81	21.96	20.04	15.63	9.82	1.94
EBIT Margin	30.67%	29.99%	30.56%	29.32%	23.48%	6.13%
Effective Tax Rate	20.66%	20.77%	20.91%	20.72%	5.19%	-

Updated Aug 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q